ADCYAP1 and Anxiety: For instance, Dore et al. found that CRH receptor antagonist can fully block intracerebroventricular pituitary adenylate cyclase-activating polypeptide (PACAP) treatment-induced anxiety behavior in the EPM test and elevated intracranial self-stimulation thresholds [56].